InvestorsHub Logo
Followers 3
Posts 437
Boards Moderated 0
Alias Born 08/01/2007

Re: hptaxis post# 5700

Monday, 11/10/2008 8:34:51 AM

Monday, November 10, 2008 8:34:51 AM

Post# of 8473
"In November 2008, we received guidance from the FDA suggesting submission of a new IND to the Division of Metabolic and Endocrine Products, or DMEP, for the investigation of Androxal for an additional potential indication as a treatment for type 2 diabetes. We plan to submit a new IND for this indication to the DMEP as soon as practicable."

Care to rethink your statements?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RPRX News